What is the recommended dosage and administration of ferrous sulfate (iron supplement) in liquid form for treating iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ferrous Sulfate Liquid Form: Dosing and Administration

For treating iron deficiency anemia with ferrous sulfate liquid, administer once daily at a dose providing 50-100 mg of elemental iron, which translates to approximately 10-20 mL of standard ferrous sulfate drops (125 mg/mL formulation providing 25 mg/mL elemental iron). 1

Recommended Dosing Strategy

Standard Dosing

  • Once-daily dosing is preferred over multiple daily doses, as studies show that 60 mg elemental iron taken once daily stimulates hepcidin levels, reducing subsequent iron absorption by 35-45%, making the overall absorption similar to divided doses 1
  • Target 50-100 mg elemental iron daily for adults with iron deficiency anemia 1
  • For ferrous sulfate liquid (drops at 125 mg/mL concentration = 25 mg/mL elemental iron), this requires approximately 2-4 mL per dose 1

Alternative Dosing for Intolerance

  • Every-other-day dosing may improve tolerability with similar or superior fractional iron absorption compared to daily dosing 1
  • If standard once-daily dosing causes gastrointestinal side effects, reduce to every-other-day administration rather than switching formulations 1

Available Liquid Formulations

The British Society of Gastroenterology guidelines identify these liquid iron preparations 1:

  • Ferrous sulfate drops: 125 mg/mL (25 mg/mL elemental iron) 1
  • Ferrous fumarate liquid: 140 mg/5 mL (45 mg/5 mL elemental iron) 1
  • Sodium feredate liquid: 190 mg/5 mL (27.5 mg/5 mL elemental iron) 1

Ferrous sulfate remains the gold standard due to established efficacy, acceptable tolerability, and lowest cost, despite being more expensive in liquid form than tablets 1, 2, 3

Administration Guidelines

Timing and Absorption Enhancement

  • Add vitamin C (ascorbic acid) to enhance iron absorption 1
  • Avoid tea and coffee within one hour of iron administration, as these are powerful inhibitors of iron absorption 1
  • Liquid preparations may be better tolerated when tablets are not 1

Treatment Duration

  • Continue therapy for approximately 3 months after hemoglobin normalization to ensure adequate repletion of marrow iron stores 1
  • Monitor hemoglobin response within the first 4 weeks; expect a rise of approximately 2 g/dL after 3-4 weeks 1

When to Switch to Intravenous Iron

Consider parenteral iron when 1:

  • Oral iron is not tolerated despite dose reduction or alternate-day dosing
  • Hemoglobin fails to increase by 1 g/dL within 2 weeks of supplementation 1
  • Ferritin levels do not improve after one month of adherent oral therapy 1
  • Conditions causing impaired absorption exist (bariatric surgery, active inflammatory bowel disease) 1

Common Pitfalls to Avoid

  • Do not prescribe multiple daily doses: This increases hepcidin levels and paradoxically reduces overall iron absorption while increasing gastrointestinal side effects 1
  • Do not delay treatment: Iron replacement therapy should not be deferred while awaiting diagnostic investigations unless colonoscopy is imminent 1
  • Do not assume treatment failure prematurely: Poor response is usually due to non-compliance, continued blood loss, or malabsorption rather than formulation inadequacy 1

Monitoring Parameters

  • Check hemoglobin at 4 weeks to confirm response 1
  • After normalization, monitor blood counts every 3 months for one year, then annually 1
  • Continue treatment for 3 months post-normalization to replenish iron stores 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral and Intravenous Iron Therapy.

Advances in experimental medicine and biology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.